Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-14.7%
5Y CAGR-0.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-14.7%/yr
vs +11.7%/yr prior
5Y CAGR
-0.8%/yr
Recent deceleration
Acceleration
-26.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.54M | -19.8% |
| 2024 | $11.89M | -10.8% |
| 2023 | $13.34M | -13.3% |
| 2022 | $15.37M | +36.3% |
| 2021 | $11.28M | +13.6% |
| 2020 | $9.93M | -18.3% |
| 2019 | $12.15M | +23.1% |
| 2018 | $9.88M | +59.7% |
| 2017 | $6.19M | +12.1% |
| 2016 | $5.52M | - |